Bonstein Sara
- SEC CIK
- 0001604019
In the past year, 4 open-market sale filings worth $2.13M and no purchases.
Current role at each company
- XLO Xilio Therapeutics, Inc.Directoras of Jun 12, 2026
- INSM INSMED IncChief Financial Officeras of Jun 5, 2026
- SCPH scPharmaceuticals Inc.Directoras of Oct 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.13M
- 4 filings
- Net
- −$2.13M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bonstein Sara as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INSM INSMED Inc
Chief Financial Officer22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Bonstein SaraChief Financial Officer | SSale | −1.15K | $25.11 | −$29.0K | −3.1%36.0K after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Bonstein SaraChief Financial Officer | SSale | −1.43K | $18.51 | −$26.5K | −2.6%54.7K after | |
| Jan 12, 2023 (view filing) | Jan 10 | 2 days | Bonstein SaraChief Financial Officer | SSale | −2.86K | $18.12 | −$51.8K | −4.1%66.0K after | |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Bonstein SaraChief Financial Officer | SSale | −3.82K | $18.95 | −$72.4K | −3.1%117.6K after | 2 lots |
| Dec 22, 2023 (view filing) | Dec 22 | Same day | Bonstein SaraChief Financial Officer | SSale | −13.2K | $30.00 | −$396.0K | −11.1%105.2K after | 10b5-1 |
| Jan 11, 2024 (view filing) | Jan 9 | 2 days | Bonstein SaraChief Financial Officer | SSale | −4.50K | $29.18 | −$131.2K | −3.8%114.1K after | |
| May 15, 2024 (view filing) | May 14 | 1 day | Bonstein SaraChief Financial Officer | SSale | −11.1K | $25.32 | −$280.7K | −8.6%117.5K after | |
| May 30, 2024 (view filing) | May 28-29 | 2 days | Bonstein SaraChief Financial Officer | SSale | −241.3K | $50.00 | −$12.1M | −67.3%117.5K after | 2 lots10b5-1 |
| Jan 10, 2025 (view filing) | Jan 7-10 | 3 days | Bonstein SaraChief Financial Officer | SSale | −6.00K | $65.43 | −$392.6K | −4.8%118.9K after | 3 lots |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Bonstein SaraChief Financial Officer | SSale | −28.4K | $80.90 | −$2.30M | −15.4%155.5K after |